Loading
Total declarations
Company
▲ Purchases (16 ops.)
▼ Sales (0 ops.)
Latest filing published 19 Nov 2008 for METABASIS THERAPEUTICS INC, €155.
Insider track record
Disclosed buys
16
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
16
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Paul K. Laikind: trading record in brief
All filings by Paul K. Laikind on record concern Metabasis Therapeutics Inc. In total, 17 filings cover trades dated from 31 August 2006 to 19 November 2008.
Purchases make up the whole of the open-market record (16 purchases, €3,055). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Since January 2008: 16 purchases and no sales on the market.
Half of the purchases are above €148 and half below.
On 19 November 2008 came the latest disclosure, an open-market purchase for €42 in Metabasis Therapeutics Inc. Publication is fast: at least half of the trades appear on SEC (Form 4) on the same day. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Paul K. Laikind
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations17 total
400 shares@ US$0.49Common StockSEC:0001179110-08-019725:0
Canonical exit: 16 Feb 2009 (T+90)
100 shares@ US$0.51Common StockSEC:0001179110-08-019725:1
Canonical exit: 16 Feb 2009 (T+90)
500 shares@ US$0.56Common StockSEC:0001179110-08-019725:2
Canonical exit: 16 Feb 2009 (T+90)
300 shares@ US$0.59Common StockSEC:0001179110-08-019725:3
Canonical exit: 16 Feb 2009 (T+90)
100 shares@ US$0.555Common StockSEC:0001179110-08-019725:4
Canonical exit: 17 Feb 2009 (T+90)
400 shares@ US$0.63Common StockSEC:0001179110-08-019725:5
Canonical exit: 17 Feb 2009 (T+90)
100 shares@ US$0.67Common StockSEC:0001179110-08-019725:6
Canonical exit: 17 Feb 2009 (T+90)
500 shares@ US$0.68Common StockSEC:0001179110-08-019725:7
Canonical exit: 17 Feb 2009 (T+90)
500 shares@ US$0.69Common StockSEC:0001179110-08-019725:8
Canonical exit: 17 Feb 2009 (T+90)
800 shares@ US$0.70Common StockSEC:0001179110-08-019725:9
Canonical exit: 17 Feb 2009 (T+90)
200 shares@ US$0.74Common StockSEC:0001179110-08-019725:10
Canonical exit: 17 Feb 2009 (T+90)
963 shares@ US$0.75Common StockSEC:0001179110-08-019725:11
Canonical exit: 17 Feb 2009 (T+90)
100 shares@ US$0.55Common StockSEC:0001179110-08-019725:12
Canonical exit: 17 Feb 2009 (T+90)
837 shares@ US$0.57Common StockSEC:0001179110-08-019725:13
Canonical exit: 17 Feb 2009 (T+90)
100 shares@ US$0.49Common StockSEC:0001179110-08-019725:14
Canonical exit: 17 Feb 2009 (T+90)
100 shares@ US$0.53Common StockSEC:0001179110-08-019725:15
Canonical exit: 17 Feb 2009 (T+90)
16,800 shares0Common StockSEC:0001104659-06-060456:0
17 of 17 declarations
